Stockreport

Aquestive Therapeutics: Biology Validated, Packaging Pending - A Forensic Analysis Of The Anaphylm CRL [Seeking Alpha]

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations
PDF The FDA's Complete Response Letter for Anaphylm is viewed as a 12-month delay, not a fundamental risk, with a 99.2% probability of NDA resubmission within a year. Mon [Read more]